Kiersten Stead authored a news article about Latus Bio's gene delivery method for brain cells. The article was published on 20 May 2025.
What Kiersten can write
DCVC writes $10M to $30M+ checks, larger than 97% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: DCVC.Career
- DCVC Bio · Managing Partner2018-present
- DCVC · Managing Partner, DCVC BioNow
Companies founded
Focus
Also at DCVC
Partners like Kiersten
At firms with a similar stage, sector and check size.
Alert me when DCVC is active
One email when Kiersten's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Kiersten Stead?
Kiersten Stead authored a news article about Latus Bio's gene delivery method for brain cells. The article was published on 20 May 2025.
How much does Kiersten Stead invest?
Kiersten Stead invests through DCVC, which writes checks of $10M to $30M+ at seed, series a.
How do I pitch Kiersten Stead?
Email [email protected], the firm's inbox for founders, and name Kiersten in the subject. A warm intro from a founder DCVC backed works better.
What did Kiersten Stead do before DCVC?
Managing Partner at DCVC Bio.
Last updated 2026-10-15. Is this you? Ask for a correction.